Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
18,261.00
20,489.00
18,867.00
18,045.00
24,618.00
33,118.00
18,254.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
18,261.00
20,489.00
18,867.00
18,045.00
24,618.00
33,118.00
18,254.00
Raw Material Cost
9,009.00
8,781.00
8,995.00
8,705.00
9,528.00
9,067.00
8,202.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
11.00
11.00
10.00
9.00
7.00
7.00
5.00
Selling and Distribution Expenses
4,927.00
5,229.00
4,476.00
5,557.00
4,665.00
4,247.00
4,303.00
Other Expenses
396.20
627.90
537.20
815.90
457.70
296.80
299.30
Total Expenditure (Excl Depreciation)
17,909.00
20,300.00
18,853.00
22,430.00
18,777.00
16,289.00
15,503.00
Operating Profit (PBDIT) excl Other Income
352
189
14
-4385
5841
16829
2751
Other Income
219.00
815.00
408.00
-180.00
421.00
-18.00
232.00
Operating Profit (PBDIT)
1,408.00
1,838.00
1,058.00
-3,936.00
6,883.00
17,458.00
3,640.00
Interest
11.00
11.00
10.00
9.00
7.00
7.00
5.00
Exceptional Items
28.00
-8.00
1.00
-2,010.00
531.00
59.00
-605.00
Gross Profit (PBDT)
9,252.00
11,708.00
9,872.00
9,340.00
15,090.00
24,051.00
10,052.00
Depreciation
837.00
834.00
636.00
629.00
621.00
647.00
657.00
Profit Before Tax
587.00
988.00
409.00
-6,586.00
6,786.00
16,864.00
2,371.00
Tax
182.00
267.00
137.00
-1,356.00
1,897.00
4,332.00
617.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
406.00
721.00
271.00
-5,230.00
4,889.00
12,532.00
1,754.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
406.00
721.00
271.00
-5,230.00
4,889.00
12,532.00
1,754.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
406.00
721.00
271.00
-5,230.00
4,889.00
12,532.00
1,754.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,45,808.00
1,47,802.00
1,47,447.00
1,52,634.00
1,55,259.00
1,54,405.00
1,42,520.00
Earnings per share (EPS)
10.72
19.04
7.12
-136.18
129.09
330.91
46.32
Diluted Earnings per share
10.72
19.04
7.12
-136.18
129.09
330.91
46.32
Operating Profit Margin (Excl OI)
1.93%
0.92%
0.07%
-24.3%
23.73%
50.82%
15.07%
Gross Profit Margin
7.8%
8.89%
5.54%
-33.01%
30.09%
52.87%
16.59%
PAT Margin
2.22%
3.52%
1.44%
-28.98%
19.86%
37.84%
9.61%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Dec 2025 is -25.82% vs 32.97% in Dec 2024
Consolidate Net Profit
YoY Growth in quarter ended Dec 2025 is -91.70% vs 87.53% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Dec 2025 is -81.60% vs 60.31% in Dec 2024
Interest
YoY Growth in quarter ended Dec 2025 is 57.14% vs 40.00% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024
Compare Quarterly Results Of Kaken Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(JPY)
Change(%)
Net Sales
18,261.00
8,991.00
9,270.00
103.10%
Other Operating Income
0.00
0.00
0.00
Total Operating income
18,261.00
8,991.00
9,270.00
103.10%
Raw Material Cost
9,009.00
2,480.00
6,529.00
263.27%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
11.00
151.00
-140.00
-92.72%
Selling and Distribution Expenses
4,927.00
2,962.00
1,965.00
66.34%
Other Expenses
396.20
538.60
-142.40
-26.44%
Total Expenditure (Excl Depreciation)
17,909.00
10,979.00
6,930.00
63.12%
Operating Profit (PBDIT) excl Other Income
352.00
-1,988.00
2,340.00
117.71%
Other Income
219.00
490.00
-271.00
-55.31%
Operating Profit (PBDIT)
1,408.00
-939.00
2,347.00
249.95%
Interest
11.00
151.00
-140.00
-92.72%
Exceptional Items
28.00
1,882.00
-1,854.00
-98.51%
Gross Profit (PBDT)
9,252.00
6,511.00
2,741.00
42.10%
Depreciation
837.00
559.00
278.00
49.73%
Profit Before Tax
587.00
231.00
356.00
154.11%
Tax
182.00
142.00
40.00
28.17%
Provisions and contingencies
0
0
0.00
Profit After Tax
406.00
34.00
372.00
1,094.12%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
406.00
34.00
372.00
1,094.12%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
55.00
-55.00
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
406.00
89.00
317.00
356.18%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
1,45,808.00
46,325.00
99,483.00
214.75%
Earnings per share (EPS)
10.72
0.28
10.44
3,728.57%
Diluted Earnings per share
10.72
0.28
10.44
3,728.57%
Operating Profit Margin (Excl OI)
1.93%
-22.11%
0.00
24.04%
Gross Profit Margin
7.80%
8.79%
0.00
-0.99%
PAT Margin
2.22%
0.38%
0.00
1.84%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,826.10 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is -10.87% vs 8.60% in Sep 2025
YoY Growth in quarter ended Dec 2025 is -25.82% vs 32.97% in Dec 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 40.60 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is -43.69% vs 166.05% in Sep 2025
YoY Growth in quarter ended Dec 2025 is -91.70% vs 87.53% in Dec 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 118.90 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is 16.23% vs 57.38% in Sep 2025
YoY Growth in quarter ended Dec 2025 is -81.60% vs 60.31% in Dec 2024
Quarterly - Interest
Interest 1.10 Million
in Dec 2025Figures in Million
QoQ Growth in quarter ended Dec 2025 is 0.00% vs 10.00% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 57.14% vs 40.00% in Dec 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 1.93%
in Dec 2025Figures in %
QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025
YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
